BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23770797)

  • 1. Effect of folic acid, vitamin B6 and vitamin B12 supplementation on mortality and cardiovascular complication among patients with chronic kidney disease: an evidence-based case report.
    Nursalim A; Siregar P; Widyahening IS
    Acta Med Indones; 2013 Apr; 45(2):150-6. PubMed ID: 23770797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
    Birn H
    Ugeskr Laeger; 2008 Mar; 170(11):933-7. PubMed ID: 18397619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials].
    Lan X; Dang SN; Zhao YL; Yan H; Yan H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1028-34. PubMed ID: 27453118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
    Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
    JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Group B vitamins as new variables related to the cardiovascular risk].
    Granieri M; Bellisarii FI; De Caterina R
    Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant reduction of serum homocysteine level and oral symptoms after different vitamin-supplement treatments in patients with burning mouth syndrome.
    Sun A; Lin HP; Wang YP; Chen HM; Cheng SJ; Chiang CP
    J Oral Pathol Med; 2013 Jul; 42(6):474-9. PubMed ID: 23297780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
    Lonn E; Held C; Arnold JM; Probstfield J; McQueen M; Micks M; Pogue J; Sheridan P; Bosch J; Genest J; Yusuf S;
    Can J Cardiol; 2006 Jan; 22(1):47-53. PubMed ID: 16450017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for lowering plasma homocysteine levels in dialysis patients.
    Nigwekar SU; Kang A; Zoungas S; Cass A; Gallagher MP; Kulshrestha S; Navaneethan SD; Perkovic V; Strippoli GF; Jardine MJ
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004683. PubMed ID: 27243372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
    Mann JF; Sheridan P; McQueen MJ; Held C; Arnold JM; Fodor G; Yusuf S; Lonn EM;
    Nephrol Dial Transplant; 2008 Feb; 23(2):645-53. PubMed ID: 18003666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine-lowering B vitamin therapy in cardiovascular prevention--wrong again?
    Lonn E
    JAMA; 2008 May; 299(17):2086-7. PubMed ID: 18460669
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine, B vitamins, and cardiovascular disease.
    Quinlivan EP; Gregory JF
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16838446
    [No Abstract]   [Full Text] [Related]  

  • 14. Homocysteine, B vitamins, and cardiovascular disease.
    Tomlinson DR; Lang D; Lewis MJ
    N Engl J Med; 2006 Jul; 355(2):209; author reply 209-11. PubMed ID: 16838444
    [No Abstract]   [Full Text] [Related]  

  • 15. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
    Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
    N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine, B vitamins, and cardiovascular disease.
    Khare A; Lopez M; Gogtay J
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16848015
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nutritional medicine 2007].
    Hauner H
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1411-3. PubMed ID: 17570092
    [No Abstract]   [Full Text] [Related]  

  • 18. Homocysteine, B vitamins, and cardiovascular disease.
    Refsum H; Smith AD
    N Engl J Med; 2006 Jul; 355(2):207; author reply 209-11. PubMed ID: 16848014
    [No Abstract]   [Full Text] [Related]  

  • 19. Homocysteine, B vitamins, and cardiovascular disease.
    Wang X; Demirtas H; Xu X
    N Engl J Med; 2006 Jul; 355(2):207-9; author reply 209-11. PubMed ID: 16838445
    [No Abstract]   [Full Text] [Related]  

  • 20. Homocysteine, B vitamins, and cardiovascular disease.
    de Craen AJ; Stott DJ; Westendorp RG
    N Engl J Med; 2006 Jul; 355(2):205-6; author reply 209-11. PubMed ID: 16837687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.